CRISPR: Their Role in Reversal of Drug Resistance and Future Prospect and Scenario
Microbes live on the Earth with supreme harmony with other organisms. They are essential for the life on earth; however they are also cause of severe ailment in animals and humans. Multiple drug-resistant bacteria are one of them. There are some pathogenic bacteria, such as Escherichia coli, Klebsiella, and Pseudomonas aeruginosa, that have evolved resistance against the last resort of drugs such as carbapenems and colistin, and now they have disseminated across Asia, Europe, and other continents. Indeed, there is no new drug currently available to challenge them. CRISPR (clustered regulatory interspaced short palindromic repeat) is a new emerging gene-editing molecular tool, which has been adopted by many biologists for editing of genome of prokaryote and eukaryotes. Now, it has been utilized to edit the antibiotic resistance gene from the bacteria. It is a precise gene-editing tool that can excise a specific gene from the DNA. CRISPR mechanism is one of the natural resistant mechanisms which is highly advanced, adaptive and provides immunity to bacteria against foreign genetic elements such as plasmids, bacteriophages, and transposons. Therefore, this abortive mechanism is engineered to utilized against the drug-resistant carrier genes.
- Altenbuchner J (2016) Editing of the Bacillus subtilis genome by the CRISPR-Cas9 system. In: Applied and environmental microbiology. p AEM-01453Google Scholar
- Datsenko KA, Pougach K, Tikhonov A, Wanner BL, Severinov K, Semenova E (2012) Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat Commun (3):945Google Scholar
- Lintner NG, Kerou M, Brumfield SK, Graham S, Liu H, Naismith JH, Sdano M, Peng N, She Q, Copié V, Young MJ (2011) Structural and functional characterization of an archaeal clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for antiviral defense (CASCADE). J Biol Chem 286(24):21643–21656CrossRefPubMedPubMedCentralGoogle Scholar
- Westra ER, van Erp PB, Künne T, Wong SP, Staals RH, Seegers CL, Bollen S, Jore MM, Semenova E, Severinov K, de Vos WM (2012) CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol Cell 46(5):595–605CrossRefPubMedPubMedCentralGoogle Scholar
- Wiedenheft B, van Duijn E, Bultema JB, Waghmare SP, Zhou K, Barendregt A, Westphal W, Heck AJ, Boekema EJ, Dickman MJ, Doudna JA (2011) RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc Natl Acad Sci 108(25):10092–10097CrossRefPubMedPubMedCentralGoogle Scholar
- Wei Y, Chesne MT, Terns RM, Terns MP (2015) Sequences spanning the leader-repeat junction mediate CRISPR adaptation to phage in Streptococcus thermophilus. Nucleic Acids Res. https://doi.org/10.1093/nar/gku1407